MGC Pharma
FEBRUARY 15, 2018
Not only would Australia get a large piece of the $55 billion global market thanks to international exports, but Medicinal Cannabis would be accessible to tens of thousands of chronic pain sufferers throughout Australia. Its future looks rich in Cannabis production, export earnings and chronic pain treatment.
The Cannigma
AUGUST 22, 2021
According to the company’s white paper , its tampons have passed FDA-mandated testing for a number of issues, including whether or not they increase the risk of toxic shock syndrome. A 2020 study looked at the use of cannabis in treating vulvodynia, a health condition that consists of chronic pain in the vulva.
Cannabis Law Report
OCTOBER 17, 2019
This white paper offers a primer to the complex and confusing global cannabis industry as it stands today. But the global legal landscape is confusing and constantly evolving, making it essential for people and businesses around the world to secure strong legal representation.
Expert insights. Personalized for you.
100 
Let's personalize your content